395 related articles for article (PubMed ID: 26598037)
1. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
3. Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study.
Johnson MJ; McDonagh TA; Harkness A; McKay SE; Dargie HJ
Eur J Heart Fail; 2002 Dec; 4(6):753-6. PubMed ID: 12453546
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial on the benefits and respiratory adverse effects of morphine for refractory dyspnea in patients with COPD: Protocol of the MORDYC study.
Verberkt CA; van den Beuken-van Everdingen MH; Franssen FM; Dirksen CD; Schols JM; Wouters EF; Janssen DJ
Contemp Clin Trials; 2016 Mar; 47():228-34. PubMed ID: 26825021
[TBL] [Abstract][Full Text] [Related]
5. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
6. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
7. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
8. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial.
Johnson MJ; Cockayne S; Currow DC; Bell K; Hicks K; Fairhurst C; Gabe R; Torgerson D; Jefferson L; Oxberry S; Ghosh J; Hogg KJ; Murphy J; Allgar V; Cleland JGF; Clark AL
ESC Heart Fail; 2019 Dec; 6(6):1149-1160. PubMed ID: 31389157
[TBL] [Abstract][Full Text] [Related]
9. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial.
Oxberry SG; Torgerson DJ; Bland JM; Clark AL; Cleland JG; Johnson MJ
Eur J Heart Fail; 2011 Sep; 13(9):1006-12. PubMed ID: 21712288
[TBL] [Abstract][Full Text] [Related]
10. Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Ferreira DH; Ekström M; Sajkov D; Vandersman Z; Eckert DJ; Currow DC
J Pain Symptom Manage; 2018 Oct; 56(4):483-492. PubMed ID: 30031217
[TBL] [Abstract][Full Text] [Related]
11. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.
Oxberry SG; Bland JM; Clark AL; Cleland JG; Johnson MJ
J Palliat Med; 2013 Mar; 16(3):250-5. PubMed ID: 23368980
[TBL] [Abstract][Full Text] [Related]
12. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
13. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.
Abernethy AP; Currow DC; Frith P; Fazekas BS; McHugh A; Bui C
BMJ; 2003 Sep; 327(7414):523-8. PubMed ID: 12958109
[TBL] [Abstract][Full Text] [Related]
14. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
[TBL] [Abstract][Full Text] [Related]
15. Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial.
Ekström M; Ferreira D; Chang S; Louw S; Johnson MJ; Eckert DJ; Fazekas B; Clark KJ; Agar MR; Currow DC;
JAMA; 2022 Nov; 328(20):2022-2032. PubMed ID: 36413230
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: A hypothesis generating study.
Martins RT; Currow DC; Abernethy AP; Johnson MJ; Toson B; Eckert DJ
Respirology; 2016 Feb; 21(2):386-91. PubMed ID: 26560987
[TBL] [Abstract][Full Text] [Related]
17. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
Currow D; Louw S; McCloud P; Fazekas B; Plummer J; McDonald CF; Agar M; Clark K; McCaffrey N; Ekström MP;
Thorax; 2020 Jan; 75(1):50-56. PubMed ID: 31558624
[TBL] [Abstract][Full Text] [Related]
18. Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.
Janowiak P; Krajnik M; Podolec Z; Bandurski T; Damps-Konstańska I; Sobański P; Currow DC; Jassem E
BMC Pulm Med; 2017 Dec; 17(1):186. PubMed ID: 29228935
[TBL] [Abstract][Full Text] [Related]
19. The impact of regular, low-dose, sustained-release morphine for chronic breathlessness on caregiver burden: An exploratory analysis of the BEAMS trial.
Kochovska S; Ferreira D; Chang S; Luckett T; Roydhouse J; Ekström M; Currow DC
Palliat Med; 2024 Jan; 38(1):156-162. PubMed ID: 37978419
[TBL] [Abstract][Full Text] [Related]
20. Testosterone Levels in People Taking Regular Low-Dose Sustained-Release Morphine for Persisting Breathlessness: An Exploratory Study.
Ferreira DH; Ekström M; Fazekas B; Currow DC
J Palliat Med; 2023 Mar; 26(3):402-405. PubMed ID: 36394475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
